Skip to main content
Clinical Trials/NL-OMON29351
NL-OMON29351
Completed
Not Applicable

Effects of a short-term dietary restriction regimen in cancer patients receiving irinotecan

Erasmus Medical Center0 sites18 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Dietary restriction FastingMetastatic colorectal carcinoma IrinotecanDieetrestrictieVastenGemetastaseerd colorectaal carcinoomIrinotecan
Sponsor
Erasmus Medical Center
Enrollment
18
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Metastatic colorectal cancer and other solid tumors
  • Treatment with irinotecan 600 mg 3\-weekly

Exclusion Criteria

  • Previous treatment with irinotecan within the last 6 months
  • Pregnant or lactating patients; patients with reproductive potential must use a reliable method of contraception (excluding oral contraceptives), if required.

Outcomes

Primary Outcomes

Not specified

Similar Trials